PeptideDB

BMS-978587 (IDO-IN-4) 1629125-65-0

BMS-978587 (IDO-IN-4) 1629125-65-0

CAS No.: 1629125-65-0

BMS-978587 (BMS978587; IDO-IN-4) is a novel and potent indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor with anticancer a
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

BMS-978587 (BMS978587; IDO-IN-4) is a novel and potent indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor with anticancer and immunompdulatory activity. Extracted from patent WO2014150677A1, Compound example 1 enantiomer 1.



Physicochemical Properties


Molecular Formula C26H35N3O3
Molecular Weight 437.574406862259
Exact Mass 437.267
CAS # 1629125-65-0
PubChem CID 118676157
Appearance Off-white to yellow solid powder
Density 1.2±0.1 g/cm3
Boiling Point 532.6±50.0 °C at 760 mmHg
Flash Point 275.9±30.1 °C
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.633
LogP 5.74
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 9
Heavy Atom Count 32
Complexity 620
Defined Atom Stereocenter Count 2
SMILES

CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[C@H]3C[C@H]3C(=O)O)N(CC(C)C)CC(C)C

InChi Key VZYCPKLOYXSKAB-FGZHOGPDSA-N
InChi Code

InChI=1S/C26H35N3O3/c1-16(2)14-29(15-17(3)4)24-11-8-19(21-13-22(21)25(30)31)12-23(24)28-26(32)27-20-9-6-18(5)7-10-20/h6-12,16-17,21-22H,13-15H2,1-5H3,(H,30,31)(H2,27,28,32)/t21-,22-/m1/s1
Chemical Name

(1R,2S)-2-[4-[bis(2-methylpropyl)amino]-3-[(4-methylphenyl)carbamoylamino]phenyl]cyclopropane-1-carboxylic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro In human IDO1/HEK293 cells, BMS-978587 (IDO-IN-4) (Compound Example 1 Enantiomer 1) functions as an IDO-1 inhibitor [1].
References

[1]. Preparation of cycloalkylaryl amide compounds as indoleamine 2,3-dioxygenase and therapeutic uses thereof. From PCT Int. Appl. (2014), WO 2014150677 A1 20140925.


Solubility Data


Solubility (In Vitro) DMSO : ≥ 100 mg/mL (~228.53 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2853 mL 11.4267 mL 22.8535 mL
5 mM 0.4571 mL 2.2853 mL 4.5707 mL
10 mM 0.2285 mL 1.1427 mL 2.2853 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.